FDA
-
-
-
-
-
-
-
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
-
-
-
-
-
-
-
NeuroOne Medical (NMTC) Issues Letter to Shareholders
-
-
-
-
-
-
-
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland
-
-
-
-
-
-
-
NeuroOne Medical (NMTC) Initiates Limited Commercial Launch of OneRF Ablation System
-
-
-
-
-
-
-
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
-
-
-
-
-
-
-
NeuroOne Medical (NMTC) Announces Proposed Public Offering of Common Stock
-
332,018 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

